Medscape Cardiology Headlines
672 news. Page : 1 2 3 4 5 6 7 8 9 10 11 12 +
The Medscape Cardiology RSS Feed Has Moved 
The Medscape Cardiology RSS feed has moved to a new location. Please update your RSS bookmark to: http://www.medscape.com/cx/rssfeeds/2669.xmlMedscape Cardiology Headlines, 2008-09-21 23:22:35
The Medscape Cardiology RSS feed has moved to a new location. Please update your RSS bookmark to: http://www.medscape.com/cx/rssfeeds/2669.xmlMedscape Cardiology Headlines, 2008-09-21 23:22:35
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study on the Effect of Oral Tolvaptan on Left Ventricular Dilation and Function in Patients With Heart Failure and Systolic Dysfunction
Does long-term use of the V2-receptor antagonist tolvaptan affect left ventricular remodeling? And is it well tolerated? Journal of the American College of CardiologyMedscape Cardiology Headlines, 2007-06-04 23:25:12
Does long-term use of the V2-receptor antagonist tolvaptan affect left ventricular remodeling? And is it well tolerated? Journal of the American College of CardiologyMedscape Cardiology Headlines, 2007-06-04 23:25:12
Coronary Venous Angioplasty and Stenting for Biventricular Pacemaker Left Ventricular Lead Implantation
The authors examined whether cardiac vein angioplasty and-or stenting would allow for the proper placement of the left ventricular lead in patients with coronary vein stenoses. The Journal of invasive cardiologyMedscape Cardiology Headlines, 2007-06-04 23:25:12
The authors examined whether cardiac vein angioplasty and-or stenting would allow for the proper placement of the left ventricular lead in patients with coronary vein stenoses. The Journal of invasive cardiologyMedscape Cardiology Headlines, 2007-06-04 23:25:12
Hypothermia Induced Prehospital Shown Feasible, Safe in Resuscitated Cardiac Arrest
In-the-field IV administration of cold normal saline slightly lowered body temperature in resuscitated patients without causing complications in a small feasibility study. HeartwireSteve StilesMedscape Cardiology Headlines, 2007-06-04 23:25:12
In-the-field IV administration of cold normal saline slightly lowered body temperature in resuscitated patients without causing complications in a small feasibility study. HeartwireSteve StilesMedscape Cardiology Headlines, 2007-06-04 23:25:12
Elevated ICAM-1 and MCP-1 Plasma Levels in Subjects at High Cardiovascular Risk Are Diminished by Atorvastatin Treatment
This large population study provides evidence that atorvastatin diminishes sICAM-1 and sMCP-1 concentrations showing anti-inflammatory effects in subjects at high cardiovascular risk. American Heart JournalMedscape Cardiology Headlines, 2007-06-04 23:25:12
This large population study provides evidence that atorvastatin diminishes sICAM-1 and sMCP-1 concentrations showing anti-inflammatory effects in subjects at high cardiovascular risk. American Heart JournalMedscape Cardiology Headlines, 2007-06-04 23:25:12
Genetic Variants Associated With Worse Heart Failure Outcomes
Researchers found additive effects in patients who have particular renin-angiotensin system alleles.Medscape Medical NewsLouise GagnonMedscape Cardiology Headlines, 2007-06-04 17:25:28
Researchers found additive effects in patients who have particular renin-angiotensin system alleles.Medscape Medical NewsLouise GagnonMedscape Cardiology Headlines, 2007-06-04 17:25:28
Type 2 Diabetes
This Journal Scan reviews the new ADA consensus statement on IFG and IGT, the controversial meta-analysis of rosiglitazone studies, and other developments in the diabetes literature. (CME)Medscape Diabetes & EndocrinologyGregory NicholsMedscape Cardiology Headlines, 2007-06-02 11:26:08
This Journal Scan reviews the new ADA consensus statement on IFG and IGT, the controversial meta-analysis of rosiglitazone studies, and other developments in the diabetes literature. (CME)Medscape Diabetes & EndocrinologyGregory NicholsMedscape Cardiology Headlines, 2007-06-02 11:26:08
MedsiteCME: Residual Cardiovascular Risk in a Patient With Existing CVD
This program highlights the risk factors for and appropriate management of residual cardiovascular risk in a patient with dyslipidemia and existing CVD. (CME)Medscape Cardiology Headlines, 2007-06-01 11:26:43
This program highlights the risk factors for and appropriate management of residual cardiovascular risk in a patient with dyslipidemia and existing CVD. (CME)Medscape Cardiology Headlines, 2007-06-01 11:26:43
Another Device Choice for Atrial Septal Defect Closure
The pivotal approval trial of a new device for the percutaneous closure of atrial septal defects has been published, showing that it is a safe and effective alternative to surgery. The HELEX septal occluder is a welcome addition to the armamentarium of pediatric cardiologists, says an accompanying editorial. HeartwireLisa NainggolanMedscape Cardiology Headlines, 2007-05-31 23:25:13
The pivotal approval trial of a new device for the percutaneous closure of atrial septal defects has been published, showing that it is a safe and effective alternative to surgery. The HELEX septal occluder is a welcome addition to the armamentarium of pediatric cardiologists, says an accompanying editorial. HeartwireLisa NainggolanMedscape Cardiology Headlines, 2007-05-31 23:25:13
CMS to Post Online Hospital 30-Day Acute-MI and Heart-Failure Mortality Rates
In a move taken to improve the quality of US hospitals, the CMS has estimated and will post risk-adjusted 30-day mortality rates for Medicare fee-for-service patients hospitalized with a discharge diagnosis of acute MI and heart failure. HeartwireMichael O'RiordanMedscape Cardiology Headlines, 2007-05-31 23:25:13
In a move taken to improve the quality of US hospitals, the CMS has estimated and will post risk-adjusted 30-day mortality rates for Medicare fee-for-service patients hospitalized with a discharge diagnosis of acute MI and heart failure. HeartwireMichael O'RiordanMedscape Cardiology Headlines, 2007-05-31 23:25:13